Skip to content

Clinical trials

Phase 1/2 Lymphoma, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 1/2 Country / region: China Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20152
20165
20174
20181
20193
20202
20215
20225
20236
20244
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status23
Recruiting12
Withdrawn5
Active, not recruiting3
Not yet recruiting2
Terminated2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd4
Chinese PLA General Hospital3
Shenzhen University General Hospital3
Wuhan Sian Medical Technology Co., Ltd3
AstraZeneca2
Han weidong2
Zhujiang Hospital2
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1
Affiliated Hospital to Academy of Military Medical Sciences1
Aibin Liang,MD,Ph.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell48
Leukemia, B-Cell12
Recurrence10
Lymphoma7
Burkitt Lymphoma5
Lymphoma, Large B-Cell, Diffuse5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Non-Hodgkin4
Lymphoma, Follicular3

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.